Theralase Technologies Inc. V.TLT

results are good

[DJDawg]

For the 13 patient's who have ever recieved the fully optimized treatment and procedure, for which we have 90 day results

2 from ph1b - CR at 90 day
8 from phase 2 CR
2 from phase 2 PR
1 NR from phase 2
(7 pending)

Our optimized CR+PR is now 92% for which the range of error for a hypothetical population is 65% to 100% at 90 days.

I'll let Enrique and others digest more and extract more that I could ever.

[riverrrow]

What I like is that there are 4 patients CR at 450 days.  Those patients must be very happy indeed.  GLTA.

[CancerSlayer]

  I like that too!...especially when you consider 2 of the 4 (from ph 1b) only received a single treatment & the other 2 of 4 received "unoptimized" treatments, highlighting this tech's potential/durability compared to currently approved treatments. Also, for the "evaluable" optimized ph 2 patients, we are currently sitting at a 73% CR rate (of the 11

[Rumpl3StiltSkin]

WOW, Still trying to wrap my head around this latest great news!!!

[CancerSlayer]

.... "evaluable" patients... A BTD app should be good to go in latter part of Q1 once we have response data on those 7 pending optimized patients...with an FDA response in Q2.  Would be happy to break $1 by then, but we know better ; )

[menoalittle]

>> an FDA response in Q2.  Would be happy to break $1 quite frankly, I suspect news of a BTD app being submitted will take over twice that   but, what do I know, eh?

[Yajne]

I agree menoalittle, but then again, we the lowly retailers have been beat into submission on our expectations. TLT should be over $1 already IMO just the fact that they're is in a bona-fide Ph2 trial which would be a better sp platform to start with after these fantastic results. At some point TLT needs to emerge from it's 'under the radar' status. What will it take? no answers

[Infinity]

I somehow felt that this clinical test result is realistic or close to realistic about 8 to 9 years ago.  It took us this long, and with so much delays in between.   We have had many screw ups during this time.   The first one was when SEC decided to jump in on some (in my opinion flimsy) grounds and created a ruling that the founder of the company can not run the company

[fredgoodwinson]

Happy with that!!!

[CancerSlayer]

Infinity wrote: "Break through Designation is not only realistic,  I think it is inevitable given the current data and comparable clinical tests being done in this area of research.   Also keep in mind,  this cure is not only effective, it is well tolerated and has the least amount of known adverse effects!!!." Agree...& The FDA's responsibility is to protect

[gojotv!]

Yes, longs' expectations have been beaten down... I suspect that the preliminary results were so good that most investors took them to be unreliable. Yet, here we are... on a continuing upswing. I'm guessing that, as the scales fall out of the market's eyes and investors big and small begin to realize that this is the cure. for. cancer...!! Momentum will begin to climb. Who wouldn

[Gooseybear]

And with BCG shortages continuing in the US along with the side effects of these treatments, I see better days ahead for TLTF. As an update to my bladder cancer, recent TURBT showed some potential  CiS but Urologist opted against additional BCG due to small amount of cancer and follow up cysto in 3 months. Also had mitomycin treatment during TURBT.

[skys1]

That's great Goosey, we all wish you continued good luck.

[fredgoodwinson]

Apologies Goosey - didn`t catch your earlier post until just now. My comment related to the Newsletter - with which I am indeed happy - rather than your own comments. As ever I wish you the very best.

[Gooseybear]

Thanks Fred.No apologies necessary. I'm feeling very positive.I have close friends and family in much more difficult places.

[fredgoodwinson]

Thanks Goosey - thoughts and best wishes to them too.

[BlueFranky]